Immunovaccine Hits 52-Week Highs on News

Immunovaccine Inc. (T.IMV) hit a new 52-week high of $2.02 Thursday. Immunovaccine announced an expansion of its ongoing collaboration with UConn Health. The collaboration is part of Immunovaccine’s DPX-NEO program, which is evaluating the anti-cancer activity of proprietary patient-specific epitopes developed at UConn Health and formulated in the Company’s DepoVax™-based vaccine formulation.

Village Farms International Inc. (T.VFF) hit a new 52-week high of $7.14 Thursday. No news announcements today

Postmedia Network Canada Corp. Class NC Variable Voting Shares (T.PNC.B) hit a new 52-week high of $2.10 Thursday. No news announcements today

Maxar Technologies Ltd. (T.MAXR) hit a new 52-week high of $85.18 Thursday. No news announcements today

Morneau Shepell Inc. (T.MSI) hit a new 52-week high of $22.40 Thursday. No news announcements today

Cott Corporation (T.BCB) hit a new 52-week high of $22.60 Thursday. No news announcements today

Boralex Inc. (T.BLX) hit a new 52-week high of $23.52 Thursday. No news announcements today

WisdomTree U.S. Quality Dividend Growth Variably Hedged Index ETF (T.DQD) hit a new 52-week high of $24.72 Thursday. No news announcements today

The Stars Group Inc. (T.TSGI) hit a new 52-week high of $30.62 Thursday. No news announcements today

Lassonde Industries Inc. (T.LAS.A) hit a new 52-week high of $258.65 Thursday. No news announcements today